题目

Business Finance Chapter 09 Quiz

单项选择题

The corporate valuation model can be used only when a company doesn't pay dividends.

选项

A.False

B.True

查看解析

标准答案

Please login to view

思路分析

Question restatement: The statement claims that the corporate valuation model can be used only when a company doesn't pay dividends. Option 1: False. The corporate valuation model (CVM) is typically used to value a firm based on free cash flow to the firm (FCFF) or equity, and it can be applied to firms that pay dividends......Login to view full explanation

登录即可查看完整答案

我们收录了全球超50000道考试原题与详细解析,现在登录,立即获得答案。

类似问题

Suppose your calculation shows that the PV of depreciation tax shield (including terminal value) is 100,000, and the PV of non-depreciation FCF (including terminal value) is 900,000. Assuming that Apple currently has 10 million shares outstanding (or 10,000 thousand shares), which range of share price would be the maximum level that you are willing to pay to acquire the firm?

Ganjaflex Industries is a major multinational conglomerate. Its business units compete in a range of industries, including home appliances, pharmaceuticals, commercial real estate, and plastics manufacturing. Although its largest business unit, which produces kitchen appliances, is among the most profitable in the industry, it generates only 35 percent of the company’s revenues. Which of the following is most likely true of Ganjaflex’s stock price?

Wing Hang Bank has EBIT of $500m and no growth. It has a cost of equity of 20%. It is currently 100% equity funded. It has an optimal capital structure of 50% debt (at 5% after-tax cost) and 50% equity (at 20% cost). What is the standalone value of Wing Hang? What is the value of control?

PharmaCo has a capital structure consisting of $10 billion in market equity and $1 billion in outstanding debt. The firm expects to generate free cash flows of $700 million next year, which are projected to grow at 3% per year in perpetuity. PharmaCo currently holds $2.6 billion in excess cash, which it plans to use entirely to finance an acquisition. Their cost of debt and equity are 3% and 7% respectively. BioEdge has $2.5 billion in market equity and $1.5 billion in debt. The firm is expected to generate $300 million in free cash flows next year, growing at 5% per year in perpetuity. BioEdge has 100 million shares outstanding, currently trading at $25 per share. Their cost of debt and equity are 7% and 10% respectively. PharmaCo is offering to acquire BioEdge using $2.6 billion in internal cash reserves. The merger is expected to generate $50 million in additional free cash flows next year, entirely from operational improvements in BioEdge, which will grow at 4% per year in perpetuity. Both firms are subject to corporate tax rate of 30%. What is the equity value of the merged firm after the transaction (in billions)?

更多留学生实用工具

希望你的学习变得更简单

加入我们，立即解锁海量真题与独家解析，让复习快人一步！